Skip to main content
Clinical Trials/IRCT20180915041040N1
IRCT20180915041040N1
Completed
未知

Comparing sudden Complete and gradual weaning on successful weaning from nasal CPAP in preterm infants

Esfahan University of Medical Sciences0 sites60 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Esfahan University of Medical Sciences
Enrollment
60
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
7 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Gestational age equal to or less than 32 weeks and birth weight equal to or less than 1800 gr
  • Starting NCPAP from first hours of birth to treat respiratory distress syndrome
  • Treatment with NCPAP after weaning from positive pressure ventilation via endotracheal route
  • The newborn should be under treatment with NCPAP for at least 24 hours
  • 5th minute APGAR score above 4

Exclusion Criteria

  • Documented congenital heart anomalies (except for small atrial septal defect, patent foramen ovale, and patent ductus arteriosus (PDA))
  • definite or possible neuromuscular disease
  • definite or possible syndrome
  • need for surgery
  • transfer to other hospital
  • patients weighing less than 750 g at the time of randomization
  • intraventricular hemorrhage (grade above 2\)
  • lung hypoplasia
  • other life\-threatening congenital anomalies
  • thoracic or airway anomalies

Outcomes

Primary Outcomes

Not specified

Similar Trials